AU2017211693B2 - 5'-phosphorothiolate mRNA 5'-end (cap) analogs, mRNA comprising the same, method of obtaining and uses thereof - Google Patents

5'-phosphorothiolate mRNA 5'-end (cap) analogs, mRNA comprising the same, method of obtaining and uses thereof Download PDF

Info

Publication number
AU2017211693B2
AU2017211693B2 AU2017211693A AU2017211693A AU2017211693B2 AU 2017211693 B2 AU2017211693 B2 AU 2017211693B2 AU 2017211693 A AU2017211693 A AU 2017211693A AU 2017211693 A AU2017211693 A AU 2017211693A AU 2017211693 B2 AU2017211693 B2 AU 2017211693B2
Authority
AU
Australia
Prior art keywords
formula
deoxy
group
thioguanosin
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017211693A
Other languages
English (en)
Other versions
AU2017211693A1 (en
Inventor
Marek Baranowski
Kaja FAC-DĄBROWSKA
Jacek Jemielity
Joanna Kowalska
Anna NOWICKA
Paweł SIKORSKI
Marcin WARMIŃSKI
Błażej WOJTCZAK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uniwersytet Warszawski
Original Assignee
Uniwersytet Warszawski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Warszawski filed Critical Uniwersytet Warszawski
Publication of AU2017211693A1 publication Critical patent/AU2017211693A1/en
Application granted granted Critical
Publication of AU2017211693B2 publication Critical patent/AU2017211693B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation
    • C07H1/04—Introducing polyphosphoric acid radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2017211693A 2016-01-29 2017-01-27 5'-phosphorothiolate mRNA 5'-end (cap) analogs, mRNA comprising the same, method of obtaining and uses thereof Active AU2017211693B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PLPL415967 2016-01-29
PL415967A PL415967A1 (pl) 2016-01-29 2016-01-29 5'-tiofosforanowe analogi końca 5' mRNA (kapu), sposób ich otrzymywania i zastosowanie
PCT/IB2017/050447 WO2017130151A1 (en) 2016-01-29 2017-01-27 5'-phosphorothiolate mrna 5'-end (cap) analogs, mrna comprising the same, method of obtaining and uses thereof

Publications (2)

Publication Number Publication Date
AU2017211693A1 AU2017211693A1 (en) 2018-08-09
AU2017211693B2 true AU2017211693B2 (en) 2021-09-09

Family

ID=58387852

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017211693A Active AU2017211693B2 (en) 2016-01-29 2017-01-27 5'-phosphorothiolate mRNA 5'-end (cap) analogs, mRNA comprising the same, method of obtaining and uses thereof

Country Status (11)

Country Link
US (1) US11066436B2 (enExample)
EP (1) EP3408276B1 (enExample)
JP (1) JP7144050B2 (enExample)
KR (1) KR102742219B1 (enExample)
CN (1) CN109071589A (enExample)
AU (1) AU2017211693B2 (enExample)
CA (1) CA3011663C (enExample)
EA (1) EA038834B1 (enExample)
ES (1) ES2879802T3 (enExample)
PL (2) PL415967A1 (enExample)
WO (1) WO2017130151A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112020002327T5 (de) * 2019-05-10 2022-07-14 New England Biolabs, Inc. Chemisches verkappen für matrizenwechsel
CN110907358B (zh) * 2019-12-09 2022-08-30 福建师范大学 一种光微流微泡腔铅离子传感器的实现装置及方法
PL432884A1 (pl) * 2020-02-12 2021-08-16 Uniwersytet Warszawski Nowe analogi kapu końca 5' mRNA, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA i peptydu
CN113278665A (zh) * 2020-08-20 2021-08-20 深圳市瑞吉生物科技有限公司 一种Cap2结构5′帽子类似物及其制备方法和应用
WO2022051677A1 (en) 2020-09-04 2022-03-10 Verve Therapeutics, Inc. Compositions and methods for capping rnas
CN119137271A (zh) * 2022-03-01 2024-12-13 维乎医疗有限公司 用于加帽rna的组合物和方法
CN114685588B (zh) * 2022-05-05 2024-03-29 江苏申基生物科技有限公司 一种含开环核苷结构的起始加帽寡核苷酸引物
CN116143855B (zh) * 2022-11-08 2023-11-28 江苏申基生物科技有限公司 一种乙烯基膦酸修饰的mRNA帽类似物及其制备方法和应用
EP4464713A1 (en) 2023-05-18 2024-11-20 Siec Badawcza Lukasiewicz - PORT Polski Osrodek Rozwoju Technologii Circular rna analogs, preparation and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008157688A2 (en) * 2007-06-19 2008-12-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008546424A (ja) * 2005-06-28 2008-12-25 アジェンコート パーソナル ジェノミクス コーポレイション 修飾ポリヌクレオチドを作製する方法および配列決定する方法
PL215513B1 (pl) * 2008-06-06 2013-12-31 Univ Warszawski Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
EP2281579A1 (en) * 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
JP6567494B2 (ja) * 2013-03-14 2019-08-28 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド ４’−チオ−修飾ヌクレオチドを有するリボ核酸及び関連方法
RS59991B1 (sr) * 2013-08-08 2020-04-30 Scripps Research Inst Metoda enzimskog in vitro obeležavanja specifičnog za položaj nukleinskih kiselina uvođenjem neprirodnih nukleotida

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008157688A2 (en) * 2007-06-19 2008-12-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap

Also Published As

Publication number Publication date
KR102742219B1 (ko) 2024-12-13
EP3408276A1 (en) 2018-12-05
CN109071589A (zh) 2018-12-21
CA3011663C (en) 2023-10-31
WO2017130151A1 (en) 2017-08-03
ES2879802T3 (es) 2021-11-23
JP7144050B2 (ja) 2022-09-29
CA3011663A1 (en) 2017-08-03
JP2019504837A (ja) 2019-02-21
US20190300563A1 (en) 2019-10-03
AU2017211693A1 (en) 2018-08-09
KR20180100595A (ko) 2018-09-11
EP3408276B1 (en) 2021-04-07
PL3408276T3 (pl) 2021-10-25
EA201891429A1 (ru) 2019-02-28
PL415967A1 (pl) 2017-07-31
US11066436B2 (en) 2021-07-20
EA038834B1 (ru) 2021-10-26

Similar Documents

Publication Publication Date Title
AU2017211693B2 (en) 5'-phosphorothiolate mRNA 5'-end (cap) analogs, mRNA comprising the same, method of obtaining and uses thereof
AU2020200699B2 (en) Methods and compositions for modulating splicing
JP7749629B2 (ja) 疾患の治療のための化合物、組成物、および方法
CN113603739B (zh) 一种加帽类似物及其应用
AU2009256131B2 (en) mRNA cap analogs
JP6388977B2 (ja) 修飾型のヌクレオシド、ヌクレオチドおよび核酸、ならびにそれらの使用方法
JP2021531022A (ja) 環状ポリリボヌクレオチドを含む組成物及びその使用
JP5998326B2 (ja) 新規核酸プロドラッグおよびその使用方法
US20250101016A1 (en) Methods and compositions for modulating splicing
Rydzik et al. mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation
CA3001014A1 (en) Mrna cap analogs and methods of mrna capping
CA3167563A1 (en) Novel mrna 5'-end cap analogs modified within phosphate residues, rna molecule incorporating the same, uses thereof and method of synthesizing rna molecule or peptide
ES2958528T3 (es) Macrociclos sustituidos útiles como inhibidores de quinasas
JP2021521831A (ja) Ｒｎａへのヌクレアーゼの小分子による標的指向動員
HK1260250A1 (en) 5′-phosphorothiolate mrna 5′-end (cap) analogs, mrna comprising the same, method of obtaining and uses thereof
Ramos et al. Ior-160, a Ck2/Hdac Dual Inhibitor, Reduces Tumor Growth by Suppressing Akt Signaling in a Xenograft Triple-Negative Breast Cancer Model
Parchina et al. discovery of an acyclic nucleoside phosphonate that inhibits mycobacterium tuberculosis ThyX based on the binding mode of a 5-alkynyl substarte analogue

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)